OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 22,965 results

Filters: rifampicin

Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
Kenneth H Rand, Herbert J Houck, Jared A Silverman
J Antimicrob Chemother. May, 2007.59(5):1017-20 Print-Electronic
Source:PubMed
PMID: 17369277 doi:10.1093/jac/dkm045
Rifampicin curing of plasmids in Escherichia coli K12-rifampicin resistant host.
E E Obaseiki-Ebor
J Pharm Pharmacol. Jul, 1984.36(7):467-70 Print
Source:PubMed
PMID: 6146694 doi:10.1111/j.2042-7158.1984.tb04428.x
Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients.
Jackson K Mukonzo, Allan Kengo, Bisaso Kutesa, Sarah Nanzigu, Anton Pohanka, Timothy D McHugh, Alimuddin Zumla, Eleni Aklillu
Trans R Soc Trop Med Hyg. 02 07, 2020.114(2):107-114 Print
Source:PubMed
PMID: 31789383 doi:10.1093/trstmh/trz108
How well do routine molecular diagnostics detect rifampicin heteroresistance in Mycobacterium tuberculosis?
Ng, K. C. S.; Supply, P.; Cobelens, F.; Gaudin, C.; Gonzalez-Martin, J.; C. de Jong, B.; Rigouts, L.
biorxiv. 2019-05-10. Preprint
Source:biorxiv
PPRID: 10.1101/632851v1 doi:10.1128/JCM.00717-19
How well do routine molecular diagnostics detect rifampicin heteroresistance in Mycobacterium tuberculosis?
Ng, K. C. S.; Supply, P.; Cobelens, F.; Gaudin, C.; Gonzalez-Martin, J.; de Jong, B. C.; Rigouts, L.
biorxiv. 2019-07-11. Preprint
Source:biorxiv
PPRID: 10.1101/632851v2 doi:10.1128/JCM.00717-19
How well do routine molecular diagnostics detect rifampicin heteroresistance in Mycobacterium tuberculosis?
Ng, K. C. S.; Supply, P.; Cobelens, F.; Gaudin, C.; Gonzalez-Martin, J.; de Jong, B. C.; Rigouts, L.
biorxiv. 2019-08-08. Preprint
Source:biorxiv
PPRID: 10.1101/632851v3 doi:10.1128/JCM.00717-19
Effect of rifampicin and tetracycline alone and in combination against Brucella suis.
J De Rycke
Ann Microbiol (Paris). 1980 Nov-Dec.131B(3):277-87 Print
Source:PubMed
PMID: 7469256 doi:
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
María E Pachón-Ibáñez, Felipe Fernández-Cuenca, Fernando Docobo-Pérez, Jerónimo Pachón, Alvaro Pascual
J Antimicrob Chemother. Sep, 2006.58(3):689-92 Print-Electronic
Source:PubMed
PMID: 16870647 doi:10.1093/jac/dkl303
Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults.
Kok-Yong Seng, Kim-Hor Hee, Gaik-Hong Soon, Nicholas Chew, Saye H Khoo, Lawrence Soon-U Lee
J Antimicrob Chemother. Dec, 2015.70(12):3298-306 Print-Electronic
Source:PubMed
PMID: 26342028 doi:10.1093/jac/dkv268
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
L J Piddock, K J Williams, V Ricci
J Antimicrob Chemother. Feb, 2000.45(2):159-65 Print
Source:PubMed
PMID: 10660497 doi:10.1093/jac/45.2.159
0